🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exercise and Diet Effects in Reducing Cardiovascular Risk in Kidney Transplant Recipients

RecruitingNAAges 30 Years - 69 YearsAllIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT06806670 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to assess whether, over an observation period of 3 years, there is a reduction in cardiovascular risk, and the extent of this reduction, in a group of adult kidney transplant patients undergoing tailored exercise combined with dietary counselling compared to a group of patients following the 'standard of care'.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinically stabilised male and female kidney transplant patients (assessment by the referring transplant centre) * Minimum age, 30 years; * Maximum age, 69 years; * Period since transplantation: from 6 months (subject to clinical stability being achieved) to 10 years; * Organ function: eGFR (CKD-EPI formula) ≥ 30 mL/min/1.73m ;2 * Obtaining informed consent; Exclusion Criteria: * Patients unable to follow the prescription, * Recent acute cardiovascular event (\< 2 months), * Unstable angina, * Hyperkinetic/hypokinetic arrhythmias not controlled by therapy, and with signs of haemodynamic impairment, * Severe aortic stenosis, * Heart failure NYHA class III-IV, FE \< 40%, * Acute illnesses that limit physical activity, * Severe hypertension (basal BP ≥200/110 mm Hg), * Neuro-musculo-skeletal pathologies that may be aggravated by exercise, * Patients unwilling to change lifestyle; * Any form of substance abuse, psychiatric disorder or condition that, according to the investigator, can complicate communication between doctor and patient; * Pregnant women.
💊

What it tests

  • lifestyle intervention
📍

Where

1 site
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy